A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients.

Clin Pharmacokinet · 2019 · PMC6768900 · PMID 31016671

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

The use of ABW (5 mg/kg) results in a similar AUC 24 across body weights as that of the reference < 100 kg group, with a slight trend towards a decreased AUC 24 with increasing body weight.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.